Rejean Idzerda is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of immunology. With a total of nine patents to his name, he has made remarkable advancements in the understanding and treatment of immune responses.

Latest Patents

Among his latest patents are "Antibodies to Interleukin-4 receptors and uses thereof," which discloses methods and compositions related to antibodies that bind to mammalian Interleukin-4 receptor proteins. Another notable patent is also titled "Antibodies to interleukin-4 receptors and uses thereof," which details mammalian Interleukin-4 receptor proteins, DNAs, and expression vectors encoding these receptors, along with processes for producing them as products of cell culture. Additionally, he has developed a method for suppressing an IL-4-dependent immune or inflammatory response in mammals, including humans, by administering an effective amount of soluble IL-4 receptor (sIL-4R) along with a suitable diluent or carrier.

Career Highlights

Rejean Idzerda has built a successful career at Immunex Corporation, where he has been instrumental in advancing therapeutic solutions for immune-related conditions. His work has not only contributed to scientific knowledge but has also paved the way for potential treatments that can improve patient outcomes.

Collaborations

Throughout his career, Rejean has collaborated with notable colleagues, including Bruce A. Mosley and David J. Cosman. These partnerships have fostered innovation and have been crucial in the development of his patented technologies.

Conclusion

Rejean Idzerda's contributions to immunology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence the development of therapies aimed at managing immune responses effectively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com